Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Maintenance Chemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00671398
What this trial is testing

Efficacy of Ramelteon on Transient Insomnia in Healthy Adults

Who this might be right for
Transient Insomnia
Takeda 289
Testing effectiveness (Phase 2)WithdrawnNCT05687721
What this trial is testing

Copanlisib and Avelumab as a Maintenance Therapy for Advanced Bladder Cancer

Who this might be right for
Advanced Urothelial Carcinoma
VA Office of Research and Development
Not applicableLooking for participantsNCT05552846
What this trial is testing

Phase II Trial of Consolidative Thoracic Radiotherapy for ES-SCLC After Standard Care of Chemo-immunotherapy

Who this might be right for
Small-cell Lung Cancer
Ruijin Hospital 104
Testing effectiveness (Phase 2)Active Not RecruitingNCT05012254
What this trial is testing

Nivolumab and Ipilimumab Plus Chemotherapy for Patients With Stage IV Lung Cancer With Brain Metastases

Who this might be right for
Non Small Cell Lung CancerBrain Metastases, AdultLung Cancer
Fundación GECP 71
Large-scale testing (Phase 3)UnknownNCT02354313
What this trial is testing

Phase III, Randomized Trial: Lenalidomide vs Observation After Induction With Rituximab Followed by Cht and ASCT in MCL Adult Patients

Who this might be right for
MANTLE CELL LYMPHOMA
Fondazione Italiana Linfomi - ETS 300
Testing effectiveness (Phase 2)UnknownNCT05425654
What this trial is testing

RL-MPV Followed by BBC HCT Using Autologous Stem Cells and Maintenance Therapy With Nivolumab for Newly Diagnosed PCNSL

Who this might be right for
Primary CNS Lymphoma
National Research Center for Hematology, Russia 30
Post-approval studies (Phase 4)UnknownNCT03026842
What this trial is testing

Decitabine Versus Conventional Chemotherapy for Maintenance Therapy of Acute Myeloid Leukemia With t(8;21)

Who this might be right for
Acute Myeloid Leukemia
The First Hospital of Jilin University 180
Testing effectiveness (Phase 2)Study completedNCT00672061
What this trial is testing

Safety of Ramelteon in Subjects With Mild to Moderate Obstructive Sleep Apnea

Who this might be right for
Sleep Apnea, Obstructive
Takeda 26
Testing effectiveness (Phase 2)Study completedNCT00777179
What this trial is testing

Phase II of Zactima Maintenance for Locally Advanced or Metastatic Non-small-cell Lung Carcinoma (NSCLC) Following Platinum-doublet Chemotherapy

Who this might be right for
NSCLC
Genzyme, a Sanofi Company 117
Large-scale testing (Phase 3)Study completedNCT02324088
What this trial is testing

Interest of Maintenance Chemotherapy After Induction Treatment for Inflammatory Breast Cancer

Who this might be right for
Inflammatory Breast Cancer
UNICANCER 174
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06063070
What this trial is testing

First-line Maintenance Treatment With Fluzoparib Plus Bevacizumab in Advanced BRCA Wild Type Ovarian Cancer

Who this might be right for
Ovarian CancerHigh Grade Serous Adenocarcinoma of OvaryHigh Grade Endometrioid Ovarian Cancer+2 more
Sun Yat-sen University 44
Testing effectiveness (Phase 2)Ended earlyNCT01972516
What this trial is testing

Tivozanib As Maintenance Therapy In GYN

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Carcinoma
Dana-Farber Cancer Institute 4
Post-approval studies (Phase 4)Study completedNCT03752216
What this trial is testing

NIraparib and Quality of LifE is a Longitudinal Study Evaluating in Real Life the Tolerability of Niraparib.

Who this might be right for
Ovarian Cancer
ARCAGY/ GINECO GROUP 141
Large-scale testing (Phase 3)Study completedNCT02603432
What this trial is testing

Avelumab In Patients With Locally Advanced Or Metastatic Urothelial Cancer (JAVELIN Bladder 100)

Who this might be right for
Urothelial Cancer
Pfizer 700
Not applicableStudy completedNCT04930341
What this trial is testing

The Effect of Self-Acupressure Application on Pain, Fatigue and Sleep Quality in Cancer Patients Receiving Chemotherapy

Who this might be right for
Cancer
Istanbul Sabahattin Zaim University 60
Large-scale testing (Phase 3)Ended earlyNCT01662102
What this trial is testing

Rituximab or Zevalin - Efficacy Trial of Therapeutic Alternatives (RoZetta)

Who this might be right for
Follicular Lymphoma
Spectrum Pharmaceuticals, Inc 1
Large-scale testing (Phase 3)Study completedNCT01631136
What this trial is testing

Strategies for Maintenance Therapies in Advanced Non Small Cell Lung Cancer

Who this might be right for
Advanced Non Small Cell Lung Cancer
Intergroupe Francophone de Cancerologie Thoracique 932
Testing effectiveness (Phase 2)UnknownNCT04733963
What this trial is testing

Fruquintinib Plus Capecitabine Versus Bevacizumab Plus Capecitabine as Maintenance Therapy Following First-line Treatment for Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine 112
Large-scale testing (Phase 3)Study completedNCT00020709
What this trial is testing

Combination Chemotherapy and Radiation Therapy With or Without Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery

Who this might be right for
Adenocarcinoma of the LungBronchoalveolar Cell Lung CancerLarge Cell Lung Cancer+3 more
National Cancer Institute (NCI) 840
Large-scale testing (Phase 3)Active Not RecruitingNCT04027309
What this trial is testing

Gilteritinib Versus Midostaurin in Combination With Induction and Consolidation Therapy Followed by One-year Maintenance in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndromes With Excess Blasts-2 With FLT3 Mutations Eligible for Intensive Chemotherapy

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome With Excess Blasts-2
Stichting Hemato-Oncologie voor Volwassenen Nederland 777
Next Page